557 692
urinary tract and urethra. Eur Urol 2014;65:825–31
. http://dx.doi. org/10.1016/j.eururo.2013.09.049.
[44] Nelles JL, Konety BR, Saigal C, Pace J, Lai J. Urologic Diseases in
America Project Urethrectomy following cystectomy for bladder
cancer in men: practice patterns and impact on survival. J Urol
2008;180:1933–6
. http://dx.doi.org/10.1016/j.juro.2008.07.039.
[45] Gakis G, Witjes JA, Comperat E, et al. EAU guidelines on primary
urethral carcinoma. Eur Urol 2013;64:823–30
. http://dx.doi.org/ 10.1016/j.eururo.2013.03.044 .[46] Giannarini G, Kessler TM, Thoeny HC, Nguyen DP, Meissner C,
Studer UE. Do patients benefit from routine follow-up to detect
recurrences after radical cystectomy and ileal orthotopic bladder
substitution? Eur Urol 2010;58:486–94
. http://dx.doi.org/10.1016/ j.eururo.2010.05.041 .[47] Varol C, Thalmann GN, Burkhard FC, Studer UE. Treatment of
urethral recurrence following radical cystectomy and ileal bladder
substitution. J Urol 2004;172:937–42
. http://dx.doi.org/10.1097/ 01.ju.0000135626.9158.7.c8 .[48] Boorjian SA, Tollefson MK, Cheville JC, Costello BA, Thapa P, Frank I.
Detection of asymptomatic recurrence during routine oncological
followup after radical cystectomy is associated with improved
patient survival. J Urol 2011;186:1796–802
. http://dx.doi.org/10. 1016/j.juro.2011.07.005.
[49]
Clark PE, Stein JP, Groshen SG, et al. The management of urethral transitional cell carcinoma after radical cystectomy for invasive bladder cancer. J Urol 2004;172:1342–7.[50] Stewart-Merrill SB, Alahdab F, Benkhadra K, et al. Oncologic sur-
veillance in bladder cancer following radical cystectomy: A sys-
tematic review and meta-analysis. Urol Oncol 2016;34:
. http://dx. doi.org/10.1016/j.urolonc.2015.11.025 ,236.e213–21.
[51] Yoshimine S, Kikuchi E, Matsumoto K, et al. The clinical significance
of urine cytology after a radical cystectomy for urothelial cancer. Int
J Urol 2010;17:527–32
. http://dx.doi.org/10.1111/j.1442-2042. 2010.02516.x .[52] Chen H, Liu L, Pambuccian SE, Barkan GA, Quek ML, Wojcik EM.
Urine cytology in monitoring recurrence in urothelial carcinoma
after radical cystectomy and urinary diversion. Cancer Cytopathol
2016;124:273–8
. http://dx.doi.org/10.1002/cncy.21650.
[53] Fernandez MI, Parikh S, Grossman HB, et al. The role of FISH and
cytology in upper urinary tract surveillance after radical cystec-
tomy for bladder cancer. Urol Oncol 2012;30:821–4
. http://dx.doi. org/10.1016/j.urolonc.2010.08.006 .[54] Yafi FA, Aprikian AG, Fradet Y, et al. Surveillance guidelines based
on recurrence patterns after radical cystectomy for bladder cancer:
the Canadian Bladder Cancer Network experience. BJU Int
2012;110:1317–23
. http://dx.doi.org/10.1111/j.1464-410X. 2012. 11133.x.
[55] Caraway NP, Khanna A, Payne L, Kamat AM, Katz RL. Combination of
cytologic evaluation and quantitative digital cytometry is reliable
in detecting recurrent disease in patients with urinary diversions.
Cancer 2007;111:323–9
. http://dx.doi.org/10.1002/cncr.22950 .[56]
Furukawa J, Miyake H, Hara I, Takenaka A, Fujisawa M. Upper urinary tract recurrence following radical cystectomy for bladder cancer. Int J Urol 2007;14:496–9.
[57]
Kim SH, Yang HK, Lee JH, Lee ES. A retrospective analysis of incidence and its associated risk factors of upper urinary tract recurrence following radical cystectomy for bladder cancer with transitional cell carcinoma: the significance of local pelvic recur- rence and positive lymph node. PloS one 2014;9:e96467.
[58]
Mitra AP, Alemozaffar M, Harris BN, Schuckman AK, Skinner EC, Daneshmand S. Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy. Urology 2014;84: 1420–6.[59]
Rink M, Ehdaie B, Cha EK, et al. Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery. Eur Urol 2012;62:677–84.
[60]
Sanderson KM, Cai J, Miranda G, Skinner DG, Stein JP. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10- year followup. J Urol 2007;177:2088–94.[61]
Tran W, Serio AM, Raj GV, et al. Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance. J Urol 2008; 179:96–100.[62]
Umbreit EC, Crispen PL, Shimko MS, Farmer SA, Blute ML, Frank I. Multifactorial, site-specific recurrence model after radical cystec- tomy for urothelial carcinoma. Cancer 2010;116:3399–407.[63]
Ichihara K, Kitamura H, Masumori N, Fukuta F, Tsukamoto T. Transurethral prostate biopsy before radical cystectomy remains clinically relevant for decision-making on urethrectomy in patients with bladder cancer. Int J Clin Oncol 2013;18:75–80.[64]
Jentzmik F, Schrader AJ, de Petriconi R, et al. The ileal neobladder in female patients with bladder cancer: long-term clinical, functional, and oncological outcome. World J Urol 2012;30:733–9.[65]
Taylor JM, Spiess PE, Kassouf W, et al. Management of urethral recurrence after orthotopic urinary diversion. BJU Int 2010;106: 56–61.E U R O P E A N U R O L O G Y 7 1 ( 2 0 1 7 ) 5 4 5 – 5 5 7
557